An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: A cross-sectional study

Revmatologiia

Volumn 40, Issue 12, 2001, Pages 1405-1412

  Ravirajan, C T ^a   Rowse, L ^a   MacGowan, J R ^a   Isenberg, D A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Nephritis; Serum autoantibodies; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA; HEPARAN SULFATE; HISTONE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN SUBCLASS; SINGLE STRANDED DNA;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NUCLEOSOME; PRIORITY JOURNAL; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; CROSS-SECTIONAL STUDIES; DNA; DNA, SINGLE-STRANDED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARITIN SULFATE; HISTONES; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; NUCLEOSOMES; SEVERITY OF ILLNESS INDEX;

EID: 0035684793     PISSN: 13100505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hahn BH. Management of systemic lupus erythematosus. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology, 4th edn. Philadelphia: W. B. Saunders, 1993:1043-9.
2. Tillman DM, Jou NT, Hill RJ, Marion TN. Both IgM and IgG anti-DNA antibodies are the product of clonally selective B cell stimulation in (NZB x NZW) F1 mice. J Exp Med 1992;176:761-79.
3. Diamond B, Katz JB, Paul E, Aranow C, Lustgarten D, Scharff MD. The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol 1992;10:731-57.
4. O'Keefe TL, Datta SK, Imanishi-kari T. Cationic residues in pathogenic anti-DNA autoantibodies arise by mutations of a germ line gene that belongs to a large VH gene subfamily. Eur J Immunol 1992;22:619-24.
5. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: A major immunogen for pathogenic autoantibody inducing T cells of lupus. J Exp Med 1993;177:1367-81.
6. Shi Y, Kaliyaperumal A, Southwood S, Sette A, Michaelis MA, Datta SK. Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor a chain. J Exp Med 1998;187:367-78.
7. Cabral AR, Alarcon-Segovia D. Autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol 1998;10:409-16.
8. Lefkowith JB, Kiehl M, Rubenstein J, DiValerio R, Bernstein K, Kahl L. Heterogeneity and clinical significance of glomerular binding antibodies in systemic lupus erythematosus. J Clin Invest 1996;98:1373-80.
9. Ravirajan CT, Rahman MA, Papadaki L et al. Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis. Eur J Immunol 1998;28:339-50.
10. Schmiedeke T, Stoeckl F, Muller S, Sugisaki Y, Batsford S, Woitas R. Glomerular immune deposits in murine lupus models may contain histones. Clin Exp Immunol 1992;90:453-8.
11. Burlingame RW, Boey ML, Starkebaum G, Rubin RL. The central role of chromatin in autoimmune response to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994;94:184-92.
12. Termaat RM, Assmann KJ, Vanson JP, Dijkman HB, Koene RA, Berden JH. Antigen specificity of antibodies bound to glomeruli of mice with systemic lupus erythematosus like syndromes. Lab Invest 1993;68:164-73.
13. Amoura Z, Koutouzov S, Piette JC. The role of nucleosomes in lupus. Curr Opin Rheumatol 2000; 12:369-73.
14. Bruns A, Blass S, Hausdorf G, Burmester GR, Hiepe F. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum 2000; 43:2307-15.
15. Amoura Z, Piette JC, Bach JF, Koutouzov S. The key role of nucleosome in lupus. Arthritis Rheum 1999; 42:833-43.
16. Foster MH, Sabbaga J, Line SR, Thompson KS, Barrett KJ, Madaio MP. Molecular analysis of spontaneous nephritogenic anti-laminin antibodies in an autoimmune MRL-1pr/1pr mouse. J Immunol 1993; 151:814-24.
17. Kramers C, Termatt R, ter Borg EJ, Van Bruggen MC, Kallenberg CG, Berden JH. Higher anti-heparan sulphate reactivity during systemic lupus erythematosus (SLE) disease exacerbations with renal manifestations: A long term prospective analysis. Clin Exp Immunol 1993; 93:34-8.
18. Lefkowith JB, Gilkeson GS. Nephritogenic autoantibodies in lupus: Current concepts and continuing controversies. Arthritis Rheum 1996;39:894-903.
19. Termaat MR, Brinkman K, van Gompel F et al. Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun 1990;3:531-45.
20. Tax WJ, Kramers C, van Bruggen C, Berden JH. Apoptosis, nucleosomes and nephritis in systemic lupus erythematosus. Kidney Int 1995;48:666-73.
21. Blanco F, Kalsi J, Ravirajan CT, Speight P, Bradwell AR, Isenberg DA. IgG subclasses in systemic lupus erythematosus and other autoimmune rheumatic diseases. Lupus 1992;1:391-9.
22. Isenberg DA, Garton M, Reichlin MW, Reichlin M. Long-term follow-up of autoantibody profiles in black female lupus patients and clinical comparisons with Caucasian and Asian patients. Br J Rheumatol 1997; 36:229-33.
23. Hay EM, Bacon PA, Gordon G et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993;86:447-58.
24. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classifications of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
25. Le Page S, Williams W, Parkhouse D et al. Relationship between lymphocytotoxic antibodies, anti-DNA antibodies and a common anti-DNA idiotype PR4 in patients with SLE, their relatives and spouses. Clin Exp Immunol 1989;77:314-8.
26. Monestier M, Fasy TM, Losman MJ, Novick KE, Muller S. Structure and binding properties of monoclonal antibodies to core histones from autoimmune mice. Mol Immunol 1993;30:1069-75.
27. Winkler TH, Jahn S, Kalden JR. IgG human anti-DNA autoantibodies from patients with systemic lupus erythematosus. Clin Exp Immunol 1991;85:379-85.
28. Davis JC, Tassiulas IO, Boumpas DT. Lupus nephritis. Curr Opin Rheumatol 1996;8:415-23.
29. Gladman DD, Goldsmith CH, Urowitz MB et al. Cross-cultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol 1992;19:608-11.
30. Harley JB, Gaither KK. Autoantibodies. Rheum Dis Clin N Am 1988;43-56.
31. Fillit H, Lahits R. Antibodies to vascular heparan sulphate proteoglycan in patients with systemic lupus erythematosus. Autoimmunity 1991;9:159-64.
32. Massa M, De Benedetti F, Pignatti P et al. Anti-dsDNA, anti-histone and anti-nucleosome IgG reactivity in children with SLE. Clin Exp Rheumatol 1994;12: 219-25.
33. Naparstek Y, Ben-Yehuda A, Cohen IR, Bar-Tana R. Crossreactivity of anti-DNA antibodies. Immunol Today 1990;11:388-9.
34. Hylkema MN, Zwet IV, Kramers C, Van Bruggen MC, Swaak AJ. No evidence for an independent role of anti-heparan sulphate reactivity apart from anti-DNA in lupus nephritis. Clin Exp Immunol 1995;101:55-9
35. Termaat RM, Brinkman K, Nossent JC, Swaak AJ, Smeenk RJ, Berden JH. Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations. Clin Exp Immunol 1990;82:268-74.
36. Kay RA, Wood KJ, Bernstein RU, Holt PJ, Pumphrey RS. An IgG subclass imbalance in connective tissue disease. Ann Rheum Dis 1988;47:536-41.
37. Devey M, Lee S, Page S, Feldman R, Isenberg DA. Serial studies of the IgG subclass and functional affinity of DNA for antibodies in systemic lupus erythematosus. J Autoimmun 1988;1:483-91.
38. Loizou S, Cofiner C, Weetman A, Walport M. Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with SLE and associated disorders. Clin Exp Immunol 1992;90:434-9.